350 results on '"Dmitrovsky, Ethan"'
Search Results
2. Human Teratocarcinomas and Retinoic Acid-Mediated Tumor Differentiation
3. Supplementary Figure S4 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
4. Supplementary Figure S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
5. Data from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
6. Supplementary Table S3 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
7. Data from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
8. Supplementary Figure S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
9. Supplementary Figure S3 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
10. Supplementary Figure S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
11. Supplementary Figure S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
12. Supplementary Table S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
13. Supplementary Table S6 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
14. Supplementary Table S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
15. Supplementary Table S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
16. Supplementary Figure S3 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
17. Supplementary Table S3 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
18. Supplementary Table S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
19. Supplementary Figure S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
20. Supplementary Figure S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
21. Supplementary Table S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
22. Supplementary Table S4 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
23. Supplementary Table S6 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
24. Abstract 1836: Combining a novel retinoic acid receptor-γ agonist with immune checkpoint blockade represses lung cancer growth in vivo
25. Supplementary Figure S4 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
26. Supplementary Table S4 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
27. Supplementary Table S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
28. Supplementary table from A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
29. Data from Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models
30. Supplementary Table S1 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
31. Data from Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models
32. Supplementary Figures 1-6 from The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
33. Data from Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown
34. supplementary figure and legend from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
35. Supplemental Fig. S3 from Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown
36. Data from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
37. Supplemental Fig. S4 from Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown
38. Data from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer
39. Supplementary Table S8 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
40. Supplemental Table S1 from Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown
41. Supplemental Figures 1-10 from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
42. Supplementary Text and Legends from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
43. Video-Supplementary Fig. 2a from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
44. Supplementary Figure 1 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target
45. Supplementary Text and Legends from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
46. Supplemental Table S1 from Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown
47. Supplementary Figure S1 from Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models
48. supplementary figure and legend from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
49. Supplementary Table S7 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
50. Supplementary Methods; Figures S1 - S22; Tables S2, S6, S9 - S12 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.